Shanghai Kehua Bio-Engineering Co Ltd (002022) - Total Liabilities

Latest as of March 2026: CN¥1.50 Billion CNY ≈ $218.93 Million USD

Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) has total liabilities worth CN¥1.50 Billion CNY (≈ $218.93 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Kehua Bio-Engineering Co Ltd - Total Liabilities Trend (2001–2025)

This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002022 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Shanghai Kehua Bio-Engineering Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Kehua Bio-Engineering Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Clinuvel Pharmaceuticals Ltd AU:CUV	Australia	AU$20.68 Million
Shenyang Chemical Industry Co Ltd SHE:000698	China	CN¥3.75 Billion
Hanjia Design Croup Co Ltd Class A SHE:300746	China	CN¥2.40 Billion
Gladstone Investment Corporation 8.00% Notes due 2028 NASDAQ:GAINL	USA	$445.37 Million
Greenyard NV BR:GREEN	Belgium	€1.59 Billion
Primis Financial Corp NASDAQ:FRST	USA	$3.83 Billion
Columbus McKinnon Corporation NASDAQ:CMCO	USA	$3.34 Billion
Egis Technology TWO:6462	Taiwan	NT$5.77 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Shanghai Kehua Bio-Engineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002022 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.58	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Kehua Bio-Engineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Kehua Bio-Engineering Co Ltd (2001–2025)

The table below shows the annual total liabilities of Shanghai Kehua Bio-Engineering Co Ltd from 2001 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.53 Billion ≈ $224.16 Million	+22.18%
2024-12-31	CN¥1.25 Billion ≈ $183.46 Million	-31.25%
2023-12-31	CN¥1.82 Billion ≈ $266.84 Million	-38.42%
2022-12-31	CN¥2.96 Billion ≈ $433.31 Million	+62.35%
2021-12-31	CN¥1.82 Billion ≈ $266.90 Million	-12.23%
2020-12-31	CN¥2.08 Billion ≈ $304.09 Million	+104.87%
2019-12-31	CN¥1.01 Billion ≈ $148.43 Million	-5.53%
2018-12-31	CN¥1.07 Billion ≈ $157.12 Million	+68.70%
2017-12-31	CN¥636.48 Million ≈ $93.14 Million	+50.66%
2016-12-31	CN¥422.47 Million ≈ $61.82 Million	+22.11%
2015-12-31	CN¥345.97 Million ≈ $50.63 Million	+114.37%
2014-12-31	CN¥161.39 Million ≈ $23.62 Million	-0.43%
2013-12-31	CN¥162.08 Million ≈ $23.72 Million	-18.57%
2012-12-31	CN¥199.05 Million ≈ $29.13 Million	+13.17%
2011-12-31	CN¥175.89 Million ≈ $25.74 Million	+13.06%
2010-12-31	CN¥155.58 Million ≈ $22.77 Million	+16.95%
2009-12-31	CN¥133.03 Million ≈ $19.47 Million	+42.18%
2008-12-31	CN¥93.56 Million ≈ $13.69 Million	-25.84%
2007-12-31	CN¥126.16 Million ≈ $18.46 Million	+45.91%
2006-12-31	CN¥86.46 Million ≈ $12.65 Million	+13.29%
2005-12-31	CN¥76.32 Million ≈ $11.17 Million	+20.16%
2004-12-31	CN¥63.51 Million ≈ $9.29 Million	-22.84%
2003-12-31	CN¥82.31 Million ≈ $12.04 Million	+3.81%
2002-12-31	CN¥79.29 Million ≈ $11.60 Million	+115.22%
2001-12-31	CN¥36.84 Million ≈ $5.39 Million	--

About Shanghai Kehua Bio-Engineering Co Ltd

SHE:002022 China Medical Devices

Market Cap

$358.26 Million

CN¥2.45 Billion CNY

Market Cap Rank

#13939 Global

#4148 in China

Share Price

CN¥4.76

Change (1 day)

-3.05%

52-Week Range

CN¥4.76 - CN¥8.06

All Time High

CN¥29.42